Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:09 PM
Study NCT ID:
NCT00410956
Status:
COMPLETED
Last Update Posted:
2024-12-10
First Post:
2006-12-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-11
First Submit QC Date:
None
Study First Post Date:
2006-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-10-29
Results First Submit QC Date:
None
Results First Post Date:
2024-12-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-05
Last Update Post Date:
2024-12-10
Last Update Post Date Type:
ACTUAL